TMH Brings FDA Approved Scalp Cooling Technology to Reduce Hair Loss in Cancer Patients

August 21, 2020

Tallahassee Memorial HealthCare (TMH) announced the introduction of the DigniCap® Scalp Cooling System, to reduce the likelihood of chemotherapy-induced hair loss in cancer patients at the Tallahassee Memorial Cancer Center. TMH is proud to offer cancer patients in the Big Bend access to the DigniCap technology.

Approved by the FDA, DigniCap® minimizes hair loss from certain chemotherapy treatments for women and men with solid tumors such as those associated with breast, ovarian, uterine, prostate and other tissues. Positive results from the multi-center FDA clinical trial, published in February 2017 by The Journal of the American Medical Association (JAMA), indicate that seven out of ten patients using the DigniCap® system kept at least 50 percent of their hair.

“For many patients, hair loss is the most emotional and troublesome side effect of chemotherapy,” said Karen Russell, MD, medical oncologist at Tallahassee Memorial HealthCare. “DigniCap® provides patients a means to reduce hair loss while maintaining self-esteem. We believe this will benefit patients and are proud to make this technology available to patients at our Cancer Center.”

The DigniCap® Scalp Cooling System consists of a computerized cooling unit managed through a touch screen display and an attached cooling cap. The cap is fitted to the head and temperature-regulated coolant continuously circulates through specially designed channels in the cooling cap. The temperature of the scalp is lowered, resulting in vasoconstriction. This narrowing of blood vessels in the scalp reduces the delivery of chemotherapy to the scalp, also reducing cellular uptake of drugs, due to decreased intra-follicular metabolic rate. These factors together reduce the risk of chemotherapy-induced hair loss.

"As the longest continuously accredited community cancer program in Florida, we are excited to be expanding our robust services to offer our patients the DigniCap® technology,” said Kathy Brooks, Oncology Administrator at Tallahassee Memorial HealthCare. “Through the efforts of our expert physicians and nurses at the Tallahassee Memorial Cancer Center, we continue to offer the highest-quality of care for cancer patients, now including a therapeutic option that addresses the most visible side effects of cancer treatments.”